Palleos Healthcare Gmbh

This study tested whether giving the immunotherapy drug atezolizumab alone for two weeks before starting chemotherapy could improve outcomes for people with triple-negative breast cancer. The trial enrolled 442 participants and compared this approach to starting atezolizumab and …

This study tested a digital health app called medidux™ to see if it could help track and reduce serious side effects in people with HER2-positive breast cancer undergoing chemotherapy and targeted therapy. The trial planned to enroll 196 adults but was terminated early. The main …